ArticleJournal of clinical and experimental hematopathology : JCEH2024

Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.

Yu Yagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.